Company / Operating Income per Share
Barinthus Biotherapeutics plc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.75
FY2025
5-year range
-$2.52 / -$0.11
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.11 to $-1.75 over the past 2 years.
Based on SEC 10-K filings.
-1.75 in FY2025.
Declined from $-0.11 to $-1.75 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 19.2% year-over-year.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.75 | +19.2% |
| FY2024 | -$2.17 | -1925.0% |
| FY2023 | -$0.11 | +91.2% |
| FY2022 | -$1.22 | +51.7% |
| FY2021 | -$2.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026